{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:57:13Z","timestamp":1762325833886,"version":"build-2065373602"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.eplepsyres.2024.107313","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T12:06:36Z","timestamp":1708085196000},"page":"107313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparing the efficacy of anti-seizure medications using matched cohorts on a large insurance claims database"],"prefix":"10.1016","volume":"201","author":[{"given":"Yoav","family":"kan-Tor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lior","family":"Ness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liran","family":"Szlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Benninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivan","family":"Ravid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Chorev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Rosen-Zvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishai","family":"Shimoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2024.107313_bib1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.yebeh.2018.10.013","article-title":"Predicting drug-resistant epilepsy \u2014 a machine learning approach based on administrative claims data","volume":"89","author":"An","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1257\/jep.31.2.3","article-title":"The state of applied econometrics: causality and policy evaluation","volume":"31","author":"Athey","year":"2017","journal-title":"J. Econ. Perspect."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib3","unstructured":"Avenue, 677 Huntington, Boston, Ma 02115, 2012. Causal Inference: What If (the book) [WWW Document]. Miguel Hernans Fac. Website. URL https:\/\/www.hsph.harvard.edu\/miguel-hernan\/causal-inference-book\/ (Accessed 6.1.23)."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jels.12333","article-title":"Examining the effects of antidiscrimination laws on children in the foster care and adoption systems","volume":"19","author":"Barak-Corren","year":"2022","journal-title":"J. Empir. Leg. Stud."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000503831","article-title":"The epidemiology of epilepsy","volume":"54","author":"Beghi","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106406","article-title":"Delays and disparities in diagnosis for adults with epilepsy: findings from U.S. Medicaid data","volume":"166","author":"Bensken","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib7","first-page":"1044","volume":"12","author":"Berger","year":"2009","journal-title":"Value Health J. Int. Soc. Pharm. Outcomes Res."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ckj\/sfab158","article-title":"An introduction to inverse probability of treatment weighting in observational research","volume":"15","author":"Chesnaye","year":"2022","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib10","doi-asserted-by":"crossref","unstructured":"Choong, J., Hakeem, H., Chen, Z., Brodie, M., Lawn, N., Drummond, T., Kwan, P., Ge, Z., 2020. Application of transformers for predicting epilepsy treatment response. https:\/\/doi.org\/10.1101\/2020.11.10.20229385.","DOI":"10.1101\/2020.11.10.20229385"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib11","doi-asserted-by":"crossref","first-page":"e2311","DOI":"10.1212\/WNL.0000000000009530","article-title":"Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures","volume":"94","author":"Chung","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/biomet\/asn055","article-title":"Dealing with limited overlap in estimation of average treatment effects","volume":"96","author":"Crump","year":"2009","journal-title":"Biometrika"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.yebeh.2015.12.039","article-title":"Changing the approach to treatment choice in epilepsy using big data","volume":"56","author":"Devinsky","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1528-1157.2003.48202.x","article-title":"Practice parameter: temporal lobe and localized neocortical resections for epilepsy","volume":"44","author":"Engel","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2018.05.019","article-title":"Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: a US database analysis","volume":"85","author":"Faught","year":"2018","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.seizure.2017.10.008","article-title":"Validating epilepsy diagnoses in routinely collected data","volume":"52","author":"Fonferko-Shadrach","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib18","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/epi.17235","article-title":"Big data analysis of ASM retention rates and expert ASM algorithm: a comparative study","volume":"63","author":"H\u00e5kansson","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/epi.16987","article-title":"Potential for improved retention rate by personalized antiseizure medication selection: a register\u2010based analysis","volume":"62","author":"H\u00e5kansson","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pediatrneurol.2023.03.016","article-title":"Selection and continuation of antiseizure medication in children with epilepsy in Sweden From 2007 to 2020","volume":"144","author":"H\u00e5kansson","year":"2023","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib21","doi-asserted-by":"crossref","first-page":"e973","DOI":"10.1212\/WNL.0000000000007004","article-title":"Claims data analyses unable to properly characterize the value of neurologists in epilepsy care","volume":"92","author":"Hill","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib22","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1212\/WNL.0000000000012514","article-title":"Definitions of drug-resistant epilepsy for administrative claims data research","volume":"97","author":"Hill","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1528-1167.2009.02201.x","article-title":"How accurate is ICD coding for epilepsy?","volume":"51","author":"Jett\u00e9","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13054-015-0847-3","article-title":"Validity of administrative data in recording sepsis: a systematic review","volume":"19","author":"Jolley","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib25","doi-asserted-by":"crossref","first-page":"e2197","DOI":"10.1212\/WNL.0000000000007448","article-title":"Assessment and effect of a gap between new-onset epilepsy diagnosis and treatment in the US","volume":"92","author":"Kalilani","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib26","article-title":"Treatment patterns in patients with a new diagnosis of epilepsy and psychiatric comorbidities","volume":"99","author":"Kalilani","year":"2019","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib27","article-title":"Using ICD-10 codes to identify elective epilepsy monitoring unit admissions from administrative billing data: A validation study","volume":"111","author":"Kamitaki","year":"2020","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5698\/1535-7597.18.4.260","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy","volume":"18","author":"Kanner","year":"2018","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5698\/1535-7597.18.4.269","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy","volume":"18","author":"Kanner","year":"2018","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib30","doi-asserted-by":"crossref","unstructured":"Kan-Tor, Y., Srebnik, N., Gavish, M., Shalit, U., Buxboim, A., 2021. Evaluating the heterogeneous effect of extended incubation to blastocyst transfer on the implantation outcome via causal inference. https:\/\/doi.org\/10.1101\/2021.11.02.466894.","DOI":"10.1101\/2021.11.02.466894"},{"issue":"Suppl 1","key":"10.1016\/j.eplepsyres.2024.107313_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pds.2329","article-title":"A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data","volume":"21","author":"Kee","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib32","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1460-9568.2011.07612.x","article-title":"Seizure-induced neurogenesis in the adult brain","volume":"33","author":"Kokaia","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.631584","article-title":"Emulated clinical trials from longitudinal real-world data efficiently identify candidates for neurological disease modification: examples from Parkinson\u2019s disease","volume":"12","author":"Laifenfeld","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib34","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/epi.16068","article-title":"The medical treatment of epilepsy in the elderly: a systematic review and meta-analysis","volume":"60","author":"Lezaic","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib35","article-title":"Causal inference as an emerging statistical approach in neurology: an example for epilepsy in the elderly","volume":"9","author":"Lm","year":"2016","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/epi.16547","article-title":"The accuracy of using administrative healthcare data to identify epilepsy cases: a systematic review of validation studies","volume":"61","author":"Mbizvo","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib38","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/epi.13691","article-title":"Accuracy of claims-based algorithms for epilepsy research: Revealing the unseen performance of claims-based studies","volume":"58","author":"Moura","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib39","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"4","author":"Nevitt","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib40","first-page":"181","article-title":"Fast and efficient feature engineering for multi-cohort analysis of EHR","author":"Ozery-Flato","year":"2017","journal-title":"Inform. Health Connect. Citiz. Led. Wellness Popul. Health"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jamiaopen\/ooaa048","article-title":"Framework for identifying drug repurposing candidates from observational healthcare data","volume":"3","author":"Ozery-Flato","year":"2020","journal-title":"JAMIA Open"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s42256-020-0197-y","article-title":"Causal inference and counterfactual prediction in machine learning for actionable healthcare","volume":"2","author":"Prosperi","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005612.pub3","article-title":"Topiramate add\u2010on for drug\u2010resistant partial epilepsy","author":"Pulman","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib44","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eplepsyres.2012.05.009","article-title":"Development and validation of a case definition for epilepsy for use with administrative health data","volume":"102","author":"Reid","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib45","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1526-4610.1998.3808595.x","article-title":"Migraine prevalence: a literature review","volume":"38","author":"Sheffield","year":"1998","journal-title":"Headache J. Head. Face Pain."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib46","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1109\/JBHI.2017.2767063","article-title":"Deep EHR: a survey of recent advances in deep learning techniques for electronic health record (EHR) analysis","volume":"22","author":"Shickel","year":"2018","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib47","unstructured":"Shimoni, Y., Karavani, E., Ravid, S., Bak, P., Ng, T.H., Alford, S.H., Meade, D., Goldschmidt, Y., 2019. An Evaluation Toolkit to Guide Model Selection and Cohort Definition in Causal Inference. ArXiv190600442 Cs Stat."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106414","article-title":"Accuracy of ICD-10-CM claims-based definitions for epilepsy and seizure type","volume":"166","author":"Smith","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/epi.12506","article-title":"Assessing the validity of using administrative data to identify patients with epilepsy","volume":"55","author":"Tu","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.seizure.2023.07.015","article-title":"Big Data \u2013 Big Trouble: The two faces of publishing results from big data studies based on cohorts with poor clinical definition","volume":"111","author":"Von Wrede","year":"2023","journal-title":"Seizure Eur. J. Epilepsy"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib51","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1038\/s41598-021-85157-x","article-title":"A machine learning approach to personalized dose adjustment of lamotrigine using noninvasive clinical parameters","volume":"11","author":"Zhu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.eplepsyres.2024.107313_bib52","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Wu, H., Wang, M.D., 2019a. Feature Exploration and Causal Inference on Mortality of Epilepsy Patients Using Insurance Claims Data. IEEE-EMBS Int. Conf. Biomed. Health Inform. IEEE-EMBS Int. Conf. Biomed. Health Inform. 2019. https:\/\/doi.org\/10.1109\/bhi.2019.8834638.","DOI":"10.1109\/BHI.2019.8834638"},{"key":"10.1016\/j.eplepsyres.2024.107313_bib53","series-title":"IEEE-EMBS Int. Conf. Biomed. Health Inform. IEEE-EMBS Int. Conf. Biomed. Health Inform","article-title":"Feature Exploration and Causal Inference on Mortality of Epilepsy Patients Using Insurance Claims Data","author":"Zhu","year":"2019"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121124000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:50:47Z","timestamp":1760277047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121124000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"alternative-id":["S0920121124000287"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107313","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the efficacy of anti-seizure medications using matched cohorts on a large insurance claims database","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2024.107313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International business machines inc. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107313"}}